Bioprognos
Early cancer diagnosis via a blood test
Total raised
€400k
€400,000
Funding rounds
1
Investors
1
distinct backers
Active since
2016-07
latest 2016-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-08-01 | Seed | €400k | Capital Cell | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel